Authors:
AGUILAR M
ALBERTI KGMM
AMIEL SA
AZZOPARDI J
BERNE C
BILOUS RW
BORCHJOHNSEN K
CATHELINEAU G
CROMME PVM
DAWSON A
ELPHICK R
ERICSSON A
HADDEN DR
HEINE RJ
HOME PD
KALO I
KANGAS T
LANDGRAF R
LAURITZEN R
MASSIBENEDETTI M
MITRAKOUFANARIOTOU A
PIEBER T
PRUIJSBRANDS A
SCHATZ H
SCHERBAUM W
SERHIYENKO A
SIERADZKI J
SWIFT P
UCCIOLI L
VANCROMBRUGGE P
WIENTJENS WHJM
YILMAZ MT
YKIJARVINEN H
Citation: M. Aguilar et al., A DESK-TOP GUIDE TO TYPE-1 (INSULIN-DEPENDENT) DIABETES-MELLITUS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(4), 1998, pp. 240-268
Authors:
KLUPA T
MALECKI MT
DAVIDSON MB
SIERADZKA J
FREY J
SIERADZKI J
KROLEWSKI AS
Citation: T. Klupa et al., AMINO-ACID VARIANTS OF THE VITAMIN-D-BINDING PROTEIN ARE NOT ASSOCIATED WITH TYPE-2 DIABETES IN CAUCASIANS, Diabetologia, 41, 1998, pp. 438-438
Citation: I. Trznadelmorawska et al., BONE-DENSITY IN TYPE-2 DIABETES IN RELATION WITH TYPE OF OBESITY ADRENAL-FUNCTION, Diabetologia, 41, 1998, pp. 1255-1255
Citation: E. Kozek et al., PROCOAGULANT PROFILE OF HEMOSTATIC PARAMETERS IN PATIENTS WITH TYPE-2DIABETES AND VISCERAL OBESITY, Diabetologia, 41, 1998, pp. 1277-1277
Authors:
SZCZEKLIK A
MUSIAL J
UNDAS A
SWADZBA J
JANKOWSKI M
SKALUBA Z
SIERADZKI J
IDZIORWALUS B
Citation: A. Szczeklik et al., EFFECT OF SIMVASTATIN TREATMENT ON THROMBIN GENERATION IN MARKED HYPERCHOLESTEROLEMIA, Thrombosis and haemostasis, 1997, pp. 1338-1338
Authors:
VIBERTI G
SLAMA G
POZZA G
CZYZYK A
BILOUS RW
GRIES A
KEEN H
FULLER JH
MENZINGER G
DIMARIO U
NAVALESI R
BRUNETTI P
PIRAS G
MUGGEO M
TIENGO A
FEDERLE D
DEFERRARI D
NOACCO C
CHARBONNEL B
SELAM J
VAGUE P
DROUIN P
HALIMI S
GRESZCZAK W
CZEKALSKI S
SIERADZKI J
FOVENYI J
KERENYI Z
KAMMERER L
SAUDEK F
VONDRA K
ANDEL M
DRORAKOVA L
HEPP KD
KOSCHINSKY T
LEHNERT H
STANDL E
MARSHALL S
BOULTON A
MACCUISH A
HYER S
Citation: G. Viberti et al., EARLY CLOSURE OF EUROPEAN PIMAGEDINE TRIAL, Lancet, 350(9072), 1997, pp. 214-215
Authors:
IDZIORWALUS B
SIERADZKI J
ROSTWOROWSKI A
ZDZIENICKA A
Citation: B. Idziorwalus et al., ASSOCIATIONS OF CHANGES IN BLOOD-LIPIDS AND HEMOSTATIC FACTORS DURINGFENOFIBRATE TREATMENT IN DYSLIPIDEMIC PATIENTS WITH POLYMETABOLIC SYNDROME (PMS), Atherosclerosis, 134(1-2), 1997, pp. 126-126
Authors:
MUSIAL J
SZCZEKLIK A
UNDAS A
SWADZBA J
JANKOWSKI M
SKALUBA Z
SIERADZKI J
IDZIORWALUS B
Citation: J. Musial et al., EFFECT OF SIMVASTATIN TREATMENT ON THROMBIN GENERATION IN MARKED HYPERCHOLESTEROLEMIA, Atherosclerosis, 134(1-2), 1997, pp. 194-194
Authors:
KOZEK E
MIRKIEWICZSIERADZKA B
SIERADZKI J
Citation: E. Kozek et al., ANTITHROMBIN-III ACTIVITY AND LEVEL OF THROMBINOGENESIS MARKERS WITH RESPECT TO THE DIABETIC-RETINOPATHY, Diabetologia, 40, 1997, pp. 1608-1608
Authors:
IDZIORWALUS B
SIERADZKI J
ROSTWOROWSKI W
ZDZIENICKA A
Citation: B. Idziorwalus et al., EFFICACY OF FENOFIBRATE TREATMENT IN POLYMETABOLIC SYNDROME (PMS) IS ASSOCIATED WITH SERUM-INSULIN LEVELS, Diabetologia, 40, 1997, pp. 1695-1695
Authors:
SIERADZKI J
GALICKALATALA D
SURDACKI A
DUBIEL J
Citation: J. Sieradzki et al., THE VALUE OF COLD PRESSURE TEST IN ASSESSMENT OF SYMPATHOVAGAL BALANCE IN IDDM PATIENTS, Diabetologia, 40, 1997, pp. 2211-2211
Authors:
WANIC K
DYNOWSKI W
KOZEK E
GALICKALATALA D
SIERADZKI J
Citation: K. Wanic et al., QT DISPERSION IN PATIENTS WITH CARDIAC AUTONOMIC NEUROPATHY DURING INSULIN-DEPENDENT DIABETES-MELLITUS, Diabetologia, 40, 1997, pp. 2262-2262
Authors:
GALICKALATALA D
SURDACKI A
DUBIEL J
SIERADZKI J
Citation: D. Galickalatala et al., AUTONOMIC NEUROPATHY IN INSULIN-DEPENDENT PATIENTS ASSESSED BY SPECTRAL HEART-RATE-VARIABILITY ANALYSIS, Diabetologia, 40, 1997, pp. 2272-2272
Authors:
TRZNADELMORAWSKA I
SIERADZKI J
OLSZANECKI P
Citation: I. Trznadelmorawska et al., EFFECT OF OBESITY ON BONE-DENSITY IN PATIENTS WITH NIDDM AND INCREASED CORTISOL LEVEL, Diabetologia, 40, 1997, pp. 2288-2288
Authors:
KOBLIK T
SIERADZKI J
FRIEDLEIN J
LEGUTKO J
Citation: T. Koblik et al., DECREASE OF AMPUTATION RATE AFTER INTRODUCTION OF FIRST POLISH INTERDISCIPLINARY DIABETIC FOOT-CARE TEAM-MODEL, Diabetologia, 40, 1997, pp. 2601-2601
Authors:
MALECKI M
BIEN AL
GALICKALATALA D
STACHURA J
SIERADZKI J
Citation: M. Malecki et al., THE PREVALENCE OF HELICOBACTER-PYLORI INFECTION AND TYPES OF GASTRITIS IN DIABETIC-PATIENTS - THE KRAKOW STUDY, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 104(5), 1996, pp. 365-369
Authors:
ROCHLITZ H
MURA R
SIERADZKI J
SCHATZ H
PFEIFFER A
Citation: H. Rochlitz et al., CHARACTERIZATION OF THE MOLECULAR SUBTYPE OF MUSCARINIC RECEPTORS IN RAT ISLETS OF LANGERHANS AND RINM5F CELLS, Diabetologia, 39, 1996, pp. 464-464
Citation: E. Kozek et J. Sieradzki, PROCOAGULANT PROFILE OF THROMBIN ACTIVATION MARKERS AND LOW PAI-1 ACTIVITY IN IDDM PATIENTS, Diabetologia, 39, 1996, pp. 903-903
Authors:
SIERADZKI J
GALICKALATALA D
SURDACKI A
DUBIEL J
Citation: J. Sieradzki et al., THE COLD PRESSURE TEST IN THE ASSESSMENT OF SYMPATHOPARASYMPATHETIC BALANCE IN DIABETIC-PATIENTS, Diabetologia, 39, 1996, pp. 956-956
Authors:
IDZIORWALUS B
SIERADZKI J
ZDZIENICKA A
ROZTWOROWSKI W
Citation: B. Idziorwalus et al., INFLUENCE OF HYPOLIPIDEMIC TREATMENT WITH FENOFIBRATE ON HEMOSTATIC FACTORS BLOOD-PRESSURE AND INSULIN LEVELS IN PATIENTS WITH POLYMETABOLIC SYNDROME, Diabetologia, 39, 1996, pp. 1043-1043
Authors:
TRZNADELMORAWSKA I
OLSZANECKI P
SIERADZKI J
Citation: I. Trznadelmorawska et al., ADVANTAGES OF ULTRASONOGRAPHIC TECHNIQUE OVER RADIOLOGICAL METHOD IN THE ASSESSMENT OF BONE-DENSITY IN DIABETES-MELLITUS, Diabetologia, 38, 1995, pp. 185-185
Citation: M. Malecki et al., THE INCIDENCE OF HELICOBACTER-PYLORI INFECTION IN DIABETICS - THE EFFECT OF AUTONOMIC NEUROPATHY, Diabetologia, 38, 1995, pp. 245-245
Authors:
GALICKALATALA D
SURDACKI A
SIERADZKI J
DUBIEL JS
Citation: D. Galickalatala et al., DETECTION OF CARDIOVASCULAR AUTONOMIC ABNORMALITIES IN TYPE-1 DIABETES BY HEART-RATE-VARIABILITY SPECTRAL-ANALYSIS, Diabetologia, 37, 1994, pp. 10000185-10000185